The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Good old tussle today with buys and sells. A prevalent 5k clip seller exiting.
Six months since they were appointed. About time we had an update.
The only thing consistent are missed timelines, RNS untruths, more raises and lack of credability/confidence. This goes lower if there is a vacumn of no news going forth.
If i was on the other side of any 'potential Memorandum of Understanding' i would be very content today. This is not the way to do business. I suspect the nomad has told him to put something out. You cannot tell the market you are testing - give dates and timelines then turn round and put a sentence in saying nothing has started. He is sailing close to the wind. How much is left in the kitty is the question that needs answering.
Well lets see what the market says...
Awful way to treat shareholders. So none the wiser on when testing date starts.
Ftse Ex - yes somewhat contradictory hence my comment about a much needed trading update. However, bear in mind this is only 2 years on the market and floated at an overpriced 122p per share and m/c of £180m. Looks cheap on current metrics. Bit of interest today.
Nice contract win and given the m/c is a paltry £15.8 m this stock is clearly undervalued. Perhaps they will include it in a long overdue trading update.
Bear in mind in the last trading update on 2 May 2023 the CEO ( and substantial shareholder of 28.53% ) stated that ' Group's clients have moved the start date of work packages, which had previously been scheduled for April and May 2023, into FY24.' and in the Full year audited resuots released on 13 Sep.'23 they staed 'Contracted Backlog growth of 44% to £67.9m (FY22: £38.2M) and Sales Bookings up 37% to £69.9m (FY22: £51.1m) '.
Therefore the next trading update is eagerly awaited. A lot of stocks are at all time lows and this is one that has a lot of potenial.
https://investors.madetech.com/share-information/
There was a lot more detail about Lotus MDA and the terms being agreed. The article, imo, didn't read well for MKA and given the fact it took place just over 3 weeks ago I can't see much movement in the short term. That, and the fact there has been a vacuum of information from the BOD on the MDA - I would have thought the BOD would have been eager to update their shareholders - had there been any material movement in the negotiation's and expected time frame.
Content to take a position at this level. Fully expect BTC to go on a further run over coming months.
Good call. Purchased some more. Fully expect news flow to increase going forwards. AA lwill drive this - looking forward to early results filtering through.
At the mercy of the swingers. At this rate the next news will be the next quarter report in Oct. Company really doesn't help itself.
J Auld is taking the proverbial here. Drawing a substantial salary while presiding over a complete s.... show. Mans got more neck than a giraffe.
Looking nicely set up for news next week. Today should be interesting.
Mr Auld is quite content to pick up his vast salary while this company flounders. There doesn't appear any motivation to be proactive in running SENX.
He should have clarified the position with Orion. It may ultimately prove to be more beneficial going the new route but he should keep Sh fully informed.
Well the finance package was due to be completed by end of May. No mention of its current status in todays RNS, which leaves it open to speculation.
I would wait to see finer points as Barr has proved he is not a man to put your trust in.
Indeed but if they have no news what can they say? Relentless larges sells been occurring daily for some considerable time.
Cast an eye over todays RNS and saw old SENX - read it - usual let down from a dreadfully run company.